Granulocyte colony-stimulating factor-primed bone marrow: An excellent stem-cell source for transplantation in acute myelocytic leukemia and chronic myelocytic leukemia

Chinese Medical Journal

Volumn 128, Issue 1, 2015, Pages 19-24

  Li, Yu Hang ^a   Jiang, Min ^a   Xu, Chen ^a   Chen, Jian Lin ^a   Li, Bo Tao ^a   Wang, Jun ^a   Hu, Jiang Wei ^a   Ning, Hong Mei ^a   Chen, Hu ^a   Chen, Shui Ping ^b   Hu, Liang Ding ^a  

^a Beijing 307 Hospital   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Bone marrow; Granulocyte colony stimulating growth factor; Human leucocyte antigen identical sibling hematopoietic stem cell transplantation; Peripheral blood stem cells

Indexed keywords

CD45 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC MYELOID LEUKEMIA; DISEASE FREE SURVIVAL; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL COUNT; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT; WHOLE BODY RADIATION; AGED; BONE MARROW; CYTOLOGY; DRUG EFFECTS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; STEM CELL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BONE MARROW; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STEM CELLS; YOUNG ADULT;

EID: 84930736005     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.147790     Document Type: Article

References (25)

1. Arcese W, Aversa F, Bandini G, De Vincentiis A, Falda M, Lanata L, et al. Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow. Haematologica 1998;83:159-82
2. Schmitz N, Beksac M, Hasenclever D, Bacigalupo A, Ruutu T, Nagler A, et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 2002;100:761-7
3. Storek J, Gooley T, Siadak M, Bensinger WI, Maloney DG, Chauncey TR, et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997;90:4705-9
4. Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, et al. Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: Results from BMTCTN 0201. J Clin Oncol 2014;32:2365-72
5. Mo XD, Xu LP, Zhang XH, Liu DH, Wang Y, Chen H, et al. Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: No difference in the high- and low-risk groups. Int J Cancer 2014
6. De Angelis G, Santarone S, Cerretti R, Picardi A, Bavaro P, Olioso P, et al. Non T-cell depleted, G-CSF primed bone marrow transplantation from haploidentical donors for patients with high-risk acute myeloid leukaemia. Bone Marrow Transplant 2011;46:S39
7. Ji SQ, Chen HR, Wang HX, Yan HM, Pan SP, Xun CQ. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia. Biol Blood Marrow Transplant 2002;8:261-7
8. Chiang KY, Haight A, Horan J, Olson E, Gartner A, Hartman D, et al. Clinical outcomes and graft characteristics in pediatric matched sibling donor transplants using granulocyte colony-stimulating factor-primed bone marrow and steady-state bone marrow. Pediatr Transplant 2007;11:279-85
9. Ji SQ, Chen HR, Xun CQ, Wang HX, Pan SP, Xiao MH. The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation. Clin Transplant 2001;15:317-23
10. Isola L, Scigliano E, Fruchtman S. Long-term follow-up after allogeneic granulocyte colony-stimulating factor-primed bone marrow transplantation. Biol Blood Marrow Transplant 2000;6:428-33
11. Couban S, Messner HA, Andreou P, Egan B, Price S, Tinker L, et al. Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: A study of 29 patients. Biol Blood Marrow Transplant 2000;6:422-7
12. Serody JS, Sparks SD, Lin Y, Capel EJ, Bigelow SH, Kirby SL, et al. Comparison of granulocyte colony-stimulating factor (G-CSF)- mobilized peripheral blood progenitor cells and G-CSF – stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant 2000;6:434-40
13. Morton J, Hutchins C, Durrant S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: Significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 2001;98:3186-91
14. Ostronoff F, Ostronoff M, Souto-Maior AP, Domingues M, Sucupira A, Manso DA, et al. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies. Clin Transplant 2009;23:33-8
15. Frangoul H, Nemecek ER, Billheimer D, Pulsipher MA, Khan S, Woolfrey A, et al. A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Blood 2007;110:4584-7
16. Kim HJ, Min WS, Cho BS, Eom KS, Kim SY, Kim YJ, et al. Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML. Bone Marrow Transplant 2009;44:345-51
17. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974;18:295-304
18. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17
19. Isola LM, Scigliano E, Skerrett D, Shank B, Ross V, Najfeld V, et al. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant 1997;20:1033-7
20. Shier LR, Schultz KR, Imren S, Regan J, Issekutz A, Sadek I, et al. Differential effects of granulocyte colony-stimulating factor on marrow and blood derived hematopoietic and immune cell populations in healthy human donors. Biol Blood Marrow Transplant 2004;10:624-34
21. Damiani D, Fanin R, Silvestri F, Grimaz S, Infanti L, Geromin A, et al. Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients. Blood 1997;90:36-42
22. Martínez C, Urbano-Ispizua A, Rozman M, Rovira M, Marín P, Montfort N, et al. Effects of short-term administration of G-CSF (filgrastim) on bone marrow progenitor cells: Analysis of serial marrow samples from normal donors. Bone Marrow Transplant 1999;23:15-9
23. Alyea EP, Soiffer RJ, Canning C, Neuberg D, Schlossman R, Pickett C, et al. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Blood 1998;91:3671-80
24. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997;276:1719-24
25. Chang YJ, Huang XJ. Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: A comprehensive review. Clin Transplant 2011;25:13-23.